News

The drug is being manufactured jointly by Bayer HealthCare and Onyx Pharmaceuticals. The approval was based on a positive data from the international, Phase III double-blind, placebo-controlled Sorafenib

The collaboration draws synergy from Lilly’s insulin expertise and Medtronic’s diabetes technologies. The alliance is expected to enhance awareness level of the people and help them benefit from

The deal with Novartis may exceed $500 million, including the initial acquisition payment plus potential additional regulatory and sales milestone payments. The agreement also includes right to an

Vernakalant is an investigational candidate used for the treatment of atrial fibrillation. As per the terms of the agreement, effectiveness of the agreement triggers an initial payment of

CLL is caused when too many abnormal white blood cells are developed in blood and bone marrow. The abnormal cells surpass the number of normal white blood cells,

Enzyme replacement therapy for the treatment of HPP is the company’s lead program. The FDA has granted fast track designation in part because HPP is an untreated, serious

Drug compositions were dynamic and customers switched to new drugs with extra features in a very short period. But, officials demanded a fresh licence to change formulation which

The company took this step in response to an appeal made by the UN and WHO to drug makers to save some of their pandemic vaccines for poor

Luciano Rossetti of Merck Research Laboratories, said: “Merck is pleased that we are now able to supply Tredaptive in approved markets and continue our long-standing commitment to help